M&A Report: Thermo Fisher Scientific (TMO) and Life Technologies Corp. (LIFE)

 

(updated M&A report)

Thermo Fisher in Agreement to Buy Life Technologies for $13.6 Billion

Thermo Fisher Scientific Inc. (TMO) and Life Technologies Corp. (LIFE), makers of laboratory equipment, have agreed to merge operations in early 2014.  Standard & Poor’s Research (S&P) reports, “We believe the proposed merger with TMO makes strategic sense with significant sales and cost synergies. The companies have complementary products with vast geographic reach, and a combination should enhance their leverage.”  The deal “gives TMO a leading presence in the fast growing next-generation sequencing market, the one area where TMO had no presence.”

TMO will pay $76 per share for Life Technologies, totalling $13.6 billion, and assume $2.2 billion in debt.  TMO is expected to grow earnings 8-9% per year for each of the next three years.

TMO had a big run-up since it broke past long-term resistance at $65 in January.  It’s current trading between $81 – $90.

LIFE shares have risen enough that shareholders could make more money by selling, and investing in another growth opportunity, vs. holding the shares until the merger.  (07/07/13)

* * * * *

(Attention website visitors: You may have access to a free one-month trial subscription, and our newsletter via email, by clicking here.  Subscribers receive access to all of the stock articles and stock portfolios on the website.)

Questions?  Contact Crista Huff at research@goodfellowllc.com.

* * * *

Investment Disclaimer

Release of Liability: Through use of this website viewing or using you agree to hold www.GoodfellowLLC.com and its employees harmless and to completely release www.GoodfellowLLC.com and its employees from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur.

Goodfellow LLC and its employees are not paid by third parties to promote nor disparage any investment. Recommendations are based on hypothetical situations of what we would do, not advice on what you should do.

Neither Goodfellow LLC nor its employees are licensed investment advisors, tax advisors, nor attorneys. Consult with a licensed investment advisor and a tax advisor to determine the suitability of any investment.

The information provided herein is obtained from sources believed to be reliable but is not guaranteed as to accuracy or completeness. When information is provided herein from third parties — such as financial news outlets, financial websites, investment firms, or any other source of financial information – the reliability or completeness of such financial information cannot be guaranteed.

The information contained on this website is provided for informational purposes only and contains no investment advice or recommendations to buy or sell any specific securities. This is not an offer or solicitation for any particular trading strategy, or confirmation of any transaction. Statements made on the website are based on the authors’ opinions and based on information available at the time this page was published. The creators are not liable for any errors, omissions or misstatements. Any performance data quoted represents past performance and past performance is not a guarantee of future results. Investments always have a degree of risk, including the potential risk of the loss of the investor’s entire principal. There is no guarantee against any loss.

* * * *

Goodfellow LLC is a subscription-only stock market website. We strive to identify financially healthy companies in which traders and investors can buy shares and earn dividends and capital gains. See disclaimer for the risks associated with investing in the stock market. See your tax advisor for the tax consequences of investing. See your estate planning attorney to clarify beneficiary and inheritance issues associated with your assets.